Sotabase

Career

· PhD Student, Biomedical Informatics, Stanford University2022–
· Intern, Google DeepMind
· SmarterDx

Publications (79)

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
The Lancet · 2023
400
cited
c‐Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma
Hepatology · 2011
180
cited
Molecular and genetic aspects of lung cancer.
American Journal of Respiratory and Critical Care Medicine · 2000
172
cited
The use of nanoparticulates to treat breast cancer.
Nanomedicine · 2017
103
cited
Phase III study of maintenance gemcitabine (G) and best supportive care (BSC) versus BSC, following standard combination therapy with gemcitabine-carboplatin (G-Cb) for patients with advanced non-small cell lung cancer (NSCLC).
2010
99
cited
Survival Outcomes of Patients with Colorectal Liver Metastases Following Hepatic Resection or Ablation in the Era of Effective Chemotherapy
Annals of Surgical Oncology · 2009
95
cited
Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma
Gut · 2010
83
cited
A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma
Investigational new drugs · 2006
69
cited
Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer
Cancer Biology & Therapy · 2011
67
cited
Assessment of K‐ras mutation
Cancer · 2009
56
cited
Many-Shot In-Context Learning in Multimodal Foundation Models
arXiv.org · 2024
55
cited
Altered Sphingolipid Metabolism in Patients with Metastatic Pancreatic Cancer
Biomolecules · 2013
51
cited
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head
American Journal of Clinical Oncology · 2020
46
cited
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
Cancer Chemotherapy and Pharmacology · 2019
36
cited
Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited.
Gastrointestinal cancer research : GCR · 2008
32
cited
Multidisciplinary Management of Early and Locally Advanced Esophageal Cancer
Journal of Clinical Gastroenterology · 2011
25
cited
Identifying circulating tumor stem cells that matter: the key to prognostication and therapeutic targeting.
Journal of Clinical Oncology · 2011
24
cited
Reirradiation for Rectal Cancer Using Pencil Beam Scanning Proton Therapy: A Single Institutional Experience
Advances in Radiation Oncology · 2020
24
cited
Multidisciplinary management of gastric cancer
Current Opinion in Gastroenterology · 2010
23
cited
Calcium: magnesium intake ratio and colorectal carcinogenesis, results from the prostate, lung, colorectal, and ovarian cancer screening trial
British Journal of Cancer · 2019
22
cited
Sotabase
Yixing Jiang | Researcher Profile | Sotabase | Sotabase